A phase II monocentric study of oxaliplatin (Ox) in combination with gemcitabine (Gem) (GEMOX) in patients (pts) with advanced/metastatic transitional cell carcinoma (TCC) of the urothelial tract ...
Gemcitabine/cisplatin in patients with advanced bladder and impaired renal function: A retrospective analysis. Phase II trial of neoadjuvant cisplatin, gemcitabine, and bevacizumab followed by radical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results